Minor Suspected

描述

Omeprazole does not have a pharmacokinetic interaction with pregabalin since pregabalin is not CYP-metabolised; however, both can cause peripheral oedema through independent mechanisms, producing additive fluid retention.

机制

Pregabalin causes peripheral oedema through an unclear mechanism, possibly related to calcium channel-mediated vascular tone changes; omeprazole rarely causes fluid retention; the combination is predominantly pharmacodynamic.

临床意义

The interaction is minor and clinically relevant only in patients prone to fluid retention (e.g., cardiac failure, hypoalbuminaemia).

处理措施

Monitor for peripheral oedema; no dose adjustment required; consider reviewing pregabalin dose if oedema worsens.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.